In liver cancer, the upregulation of microRNA-17-5p can decrease PTEN gene expression 79, which is a significant inhibitor of the PI3K/AKT pathway 80, thereby activating the PI3K/AKT signaling pathway and promoting glycolysis. This evidence concerns the gene AKT1 and liver cancer.